Skip to main content
Home U.S.- CHINA | ECONOMIC and SECURITY REVIEW COMMISSION

U.S.-China Economic AND Security Review Commission

  • About Us
    hearings navigation
    About the Commission

    The U.S.-China Economic and Security Review Commission is a legislative branch commission created by the United States Congress in October 2000 with the legislative mandate to monitor, investigate, and submit to Congress an annual report on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China, and to provide recommendations, where appropriate, to Congress for legislative and administrative action.

    About the Commission
    • Charter
    • Commission Members
    • Commission Staff
    • Job Opportunities
    • Contact Us
  • Annual Reports
  • Recommendations
  • Hearings
  • Research
    research navigation menu drop down
    Research

    The U.S.-China Economic and Security Review Commission is chartered to monitor, investigate, and report to Congress on the national security implications of the bilateral trade and economic relationship between the United States and the People’s Republic of China. The Commission meets its research mission by submitting to Congress an Annual Report, as well as by conducting staff-led reports, contracted research, and more.

    View All Research
    • RESEARCH BY TOPIC
      Censorship and Control RESEARCH BY TOPIC
    • China’s Economy and Resources
    • Compliance with International Rules and Norms
    • Finance and Investment
    • Global Relations and Influence
    • Hong Kong
    • Product Safety
    • Science and Technology
    • Security and Defense
    • Taiwan
    • Trade and Supply Chains
    • FEATURED RESEARCH
      Chinese Companies Listed on Major U.S. Stock Exchanges FEATURED RESEARCH
    • PRC in International Organizations
    • China-Ukraine Timeline

Search

Exploring the Growing U.S. Reliance on China's Biotech and Pharmaceutical Products

AGENDA


Hearing on “Exploring the Growing U.S. Reliance on China's Biotech and Pharmaceutical Products”

Wednesday, July 31, 2019

Russell Senate Office Building 428A

Unable to see this video? Click here.

9:30 AM – 9:35 AM: Opening Remarks: Senator Jim Talent and Commissioner Michael Wessel

9:35 AM – 10:20 AM:  Panel I: Administration Views on Chinese Pharmaceutical, Medical Product, and Biotechnology Development and Sourcing

  • Christopher Priest, Chief of Staff, Defense Health Agency Operations Directorate (J-3) [Testimony]
  • Mark Abdoo, Associate Commissioner for Global Policy and Strategy, Food and Drug Administration [Statement for the Record]

10:35: AM – 12:35 PM:  Panel II: China’s Role in Global Health and Activities in the United States

  • Rosemary Gibson, Senior Advisor, Hastings Center, Author, “China Rx” [Testimony]
  • Ben Westhoff, Author, “Fentanyl, Inc.” [Testimony]
  • Dr. Jennifer Bouey, Tang Chair in China Policy Studies, RAND Corporation; Associate Professor, Georgetown University’s School of Nursing and Health Studies [Testimony]
  • Dr. Mark Kazmierczak, Scientist and Associate, Gryphon Scientific LLC [Testimony]

12:35 PM – 1:30 PM:  Lunch Break

1:30 PM – 3:30 PM:  Panel III: U.S.-China Links in Health and Medical Products: Risks and Opportunities

  • Benjamin Shobert, Director of Strategy for Health Business Strategy, Microsoft; Senior Associate, National Bureau of Asian Research [Testimony]
  • Katherine Eban, Author, “Bottle of Lies” [Testimony]
  • Dr. Yanzhong Huang, Senior Fellow for Global Health, Council on Foreign Relations; Professor, School of Diplomacy and International Relations, Seton Hall University [Testimony]
  • Craig Allen, President, US-China Business Council [Testimony]

3:35 PM:  Adjourn

Transcript
July 31, 2019 Hearing Transcript.pdf5.21 MB

Subscribe To Our Mailing List

CAPTCHA

U.S.-CHINA

U.S.-China Economic and
Security Review Commission

444 North Capitol Street NW, Suite 602
Washington, DC 20001

202-624-1407linkedintwitter

Footer menu

  • Contact Us
  • All Announcements
  • Privacy
  • Accessibility